• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫活性的 Ferumoxytol-聚(I:C)纳米材料通过调节髓源抑制性细胞分化抑制转移性黑色素瘤。

Immunologically active ferumoxytol-poly(I : C) nanomaterials inhibit metastatic melanoma by regulating myeloid-derived suppressor cell differentiation.

机构信息

Jiangsu Key Laboratory of Phylogenomics and Comparative Genomics, Jiangsu Joint International Center of Genomics, School of Life Sciences, Jiangsu Normal University, Xuzhou, 221116, Jiangsu Province, China.

Department of Urology, Xuzhou Central Hospital, Xuzhou, 221009, China.

出版信息

Biomater Sci. 2023 Jul 25;11(15):5337-5346. doi: 10.1039/d3bm00416c.

DOI:10.1039/d3bm00416c
PMID:37366334
Abstract

Nanomaterials have been identified as a potential therapeutic option for targeting myeloid-derived suppressor cells (MDSCs), which are known to play a crucial role in tumor metastasis and treatment resistance. Here, we report a unique immunologically active nanomaterial composed of ferumoxytol and poly(I : C) (FP-NPs) and investigate its immunoregulatory activities on MDSCs in metastatic melanoma. assays demonstrated that FP-NPs had the ability to significantly impede the progression of metastatic melanoma and decrease the MDSC population in the lungs, spleen, and bone marrow of mice. Both and experiments revealed that FP-NPs reduced the number of granulocytic MDSCs and promoted the differentiation of monocytic MDSCs into anti-tumor M1 macrophages. Transcriptome sequencing indicated that FP-NPs significantly altered the expression of several genes involved in immunity. Analysis of Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and quantitative real-time PCR revealed that FP-NPs significantly increased the expression of the myeloid cell differentiation-related gene interferon regulatory factor 7 and activated interferon beta-related signaling pathways, which stimulated the differentiation of MDSCs into M1 macrophages. These findings suggest that FP-NPs, a unique nanomaterial with immunological properties, can induce MDSCs to differentiate into M1 macrophages, potentially offering new treatment prospects for metastatic melanoma in the future.

摘要

纳米材料已被确定为一种有潜力的治疗方法,可用于靶向髓系来源的抑制细胞(MDSCs),这些细胞已知在肿瘤转移和治疗耐药中发挥关键作用。在这里,我们报告了一种由 Ferumoxytol 和聚(I:C)组成的独特免疫活性纳米材料(FP-NPs),并研究了其对转移性黑色素瘤中 MDSCs 的免疫调节作用。体内实验表明,FP-NPs 能够显著抑制转移性黑色素瘤的进展,并减少小鼠肺部、脾脏和骨髓中的 MDSC 群体。体内和体外实验均表明,FP-NPs 减少了粒细胞 MDSC 的数量,并促进单核细胞 MDSC 向抗肿瘤 M1 巨噬细胞分化。转录组测序表明,FP-NPs 显著改变了几个与免疫相关的基因的表达。基因本体论、京都基因与基因组百科全书和实时定量 PCR 分析表明,FP-NPs 显著增加了与髓样细胞分化相关的基因干扰素调节因子 7 的表达,并激活了干扰素 β 相关信号通路,从而刺激 MDSC 向 M1 巨噬细胞分化。这些发现表明,FP-NPs 作为一种具有免疫特性的独特纳米材料,可诱导 MDSC 向 M1 巨噬细胞分化,为未来转移性黑色素瘤的治疗提供了新的前景。

相似文献

1
Immunologically active ferumoxytol-poly(I : C) nanomaterials inhibit metastatic melanoma by regulating myeloid-derived suppressor cell differentiation.免疫活性的 Ferumoxytol-聚(I:C)纳米材料通过调节髓源抑制性细胞分化抑制转移性黑色素瘤。
Biomater Sci. 2023 Jul 25;11(15):5337-5346. doi: 10.1039/d3bm00416c.
2
Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression.经铁氧体纳米颗粒(ferumoxytol)激活的抗肿瘤巨噬细胞与 TLR3 激动剂聚(I:C)联合或表面功能化,可促进黑色素瘤消退。
Theranostics. 2018 Nov 29;8(22):6307-6321. doi: 10.7150/thno.29746. eCollection 2018.
3
Decitabine suppresses MDSC-induced immunosuppression through dual functional mechanism and inhibits melanoma metastasis.地西他滨通过双重功能机制抑制 MDSC 诱导的免疫抑制作用,并抑制黑色素瘤转移。
Med Oncol. 2024 May 31;41(7):165. doi: 10.1007/s12032-024-02320-w.
4
Visualization and quantification of homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.可视化和量化髓源性抑制细胞在原发性和转移性癌症中的归巢动力学。
Theranostics. 2019 Aug 12;9(20):5869-5885. doi: 10.7150/thno.33275. eCollection 2019.
5
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.靶向髓源抑制性细胞联合原发性乳腺肿瘤切除术可减少肺部转移生长。
Breast Cancer Res. 2019 Sep 5;21(1):103. doi: 10.1186/s13058-019-1189-x.
6
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.PMN-MDSCs 通过 ROS/Notch/Nodal 信号的相互作用增强 CTC 的转移特性。
Int J Mol Sci. 2019 Apr 18;20(8):1916. doi: 10.3390/ijms20081916.
7
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.干扰素调节因子 4(IRF4)控制髓系来源的抑制细胞(MDSC)分化和功能。
J Leukoc Biol. 2016 Dec;100(6):1273-1284. doi: 10.1189/jlb.1A0215-068RR. Epub 2016 Sep 6.
8
MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.miR-30a 通过靶向 SOCS3 增加 B 细胞淋巴瘤小鼠中 MDSC 的分化和免疫抑制功能。
FEBS J. 2017 Aug;284(15):2410-2424. doi: 10.1111/febs.14133. Epub 2017 Jul 21.
9
[Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].[重组高迁移率族蛋白B1在体外诱导小鼠髓系细胞分化为髓源性抑制细胞]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Oct;32(10):1362-1365.
10
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.TAM 家族受体激酶抑制逆转 MDSC 介导的抑制作用,并增强黑色素瘤的抗 PD-1 治疗。
Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.